Altimmune Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALT Nasdaq 2834 http://www.altimmune.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Altimmune Inc

Altimmune Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Nov 30th, 2018 4:06 pm
Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer - Nov 27th, 2018 7:00 am
Today's Research Reports on Trending Tickers: Altimmune and Johnson & Johnson - Nov 23rd, 2018 5:00 am
Altimmune Announces Third Quarter 2018 Financial Results and Provides Corporate Update - Nov 13th, 2018 2:50 pm
Altimmune to Present at Dawson James Securities 4th Annual Small Cap Growth Conference - Oct 26th, 2018 9:29 am
Gaithersburg biotech CEO to step down - Oct 23rd, 2018 1:05 pm
Today’s Research Reports on Stocks to Watch: Altimmune and MannKind - Oct 17th, 2018 6:00 am
Why Altimmune Stock Is Sliding Lower Today - Oct 8th, 2018 10:35 am
Altimmune Announces $25 million Registered Direct Offering - Oct 8th, 2018 7:00 am
Altimmune Closes on $16.9 Million in Funding - Oct 3rd, 2018 6:00 am
Today’s Research Reports on Stocks to Watch: Aytu Bioscience and Altimmune - Oct 1st, 2018 6:00 am
Altimmune Announces Pricing of $12 Million Underwritten Public Offering - Sep 28th, 2018 7:01 am
Altimmune Announces $4.9 million Registered Direct Offering of Common Stock - Sep 24th, 2018 7:00 am
Altimmune Awarded $2.5 Million in Additional BARDA Funding to Support NasoShield™ Development - Sep 24th, 2018 6:00 am
Today’s Research Reports on Stocks to Watch: Molecular Templates and Altimmune - Sep 20th, 2018 6:00 am
Why Altimmune Stock Is Skyrocketing Today - Sep 19th, 2018 3:16 pm
Altimmune, Inc. to Host Earnings Call - Aug 15th, 2018 4:30 am